Volunteers Needed for Inhaled Insulin StudyJuly 27th, 2005 Researchers at Indiana University School of Medicine are looking for 400 people with type 1 diabetes to volunteer for a study of an inhaled insulin treatment. The Indiana University School of Medicine is one of 70 sites around the world testing the treatment developed by Indianapolis-based Eli Lilly and Co.
INGAP closer to cure diabetesMarch 18th, 2005 LOS ANGELES -- Researchers might be getting closer to finding a cure for diabetes. Researchers announced a new treatment and medicine, and the discovery of a gene that might play a role.
New hope for people with hepatitis CMay 23rd, 2005 University of New South Wales (UNSW) researchers are running two new studies on hepatitis C, which could revolutionise treatment for the virus. It is hoped that one study could lead to cure rates of almost 100 percent in those who have just been infected with the virus.
New Therapy for Diabetic Peripheral Neuropathy using monochromatic infrared photo energyApril 7th, 2005 for those afflicted with Diabetic Peripheral Neuropathy (DPN), Missouri Southern Healthcare has a new therapy program that has shown great strides in returning circulation to feet, lowering the pain and frequency of falls that most people with diabetes suffer. The therapy must be given in 40-minute increments three times a week for 10 to 20 weeks.
Parkinson's Disease Treatment Leads to Compulsive GamblingAugust 11th, 2005 Researchers have identified excessive gambling as a side effect of a treatment for Parkinson's disease. Some patients who are prescribed medication known as dopamine agonists developed the problem within three months of starting treatment, even though they had previously gambled only occasionally or never at all.
Keryx announces positive interim results for mid stage trial drug for diabetic nephropathy treatmentMay 7th, 2005 Keryx Biopharmaceuticals (KERX) Announces Positive Interim Results From Phase 2 Clinical Study For KRX-101 (Sulodexide Gelcaps) For Treatment Of Diabetic Nephropathy. Around 40% of diabetic patients progress to diabetic nephropathy.
AIIMS / Indian Government Ideal For DCA Human Trial For Cancer TreatmentFebruary 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.
HIV Breakthrough Study in US Raises Hopes for a Cure FinallyAugust 13th, 2005 A cheap drug, enfurvitide, has shown promise in stamping out hidden pockets of HIV in three people who have long been infected with the virus. The result is described by the US scientists as merely a “proof of concept”, but has inevitably sparked talk of a cure for AIDS.
Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 AntibodyJuly 17th, 2005 The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising.
Self-Treatment With DCA for CancerFebruary 27th, 2007 DCA has generated quite an interest in patients with Cancer, many even contemplating self-treatment for cure. The key points we know about DCA so far are:
1.
Korean Study Demonstrates Feasibility of Efficiently Harvesting Genetically Identical Stem Cells from Egg DonorsMay 20th, 2005 Korean Scientists lead by Woo Suk Hwang and Shing Yong Moon of Seoul National University in Korea have successfully generated new lines of human embryonic stem cells that are exact genetic matches for individual patients, according to a new study. The researchers derived stem cells from patients with spinal cord injury, a congenital immune disorder and juvenile diabetes.
Significant Progress in Haemophilia Treatment using Gene TherapyAugust 15th, 2005 Impressive progress has been made in the treatment of haemophilia using gene therapy. Professor Katherine High, a leading researcher from Philadelphia USA, is examining the obstacles to successful gene therapy in human patients with haemophilia.
Ruboxistaurin (RBX) May Reduce Risk of Vision Loss in DiabeticsJuly 16th, 2005 A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association’s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema.
Diabetes Treatment by Consuming TeaAugust 9th, 2005 Study conducted by researchers at the University of Scranton suggests that tea might prevent diabetes and its associated complications, including diabetic cataracts. Researchers led by Joe Vinson fed green and black tea to diabetic rats for three months and then monitored the chemical composition of the rats' blood and eye lenses.
AIIMS pioneers stem cell injection for reviving heart musclesFebruary 24th, 2005 It can now be announced that AIIMS has marked a global first in pioneering stem cell medicine by the "injection method", placing the institute right at the top of the world's medicine map. This is very exciting news for diabetics and heart transplant patients.